ghk-cu copper peptide structure CAS#: 49557-75-7 Blue copper peptide (GHK-Cu): the
Description
Tolerogenic peptide therapy aims instead to induce immune tolerance to self-antigens by selectively targeting and suppressing self-reactive T cells, while promoting the expansion of regulatory T cells (T regs ) and tolerogenic dendritic cells (DCs)

BPC-157 & TB500 BLEND - Research Grade Peptide

Outcomes Pain Relief ACI has shown significant pain relief in patients with large or deep cartilage defects, especially in younger patients

In our upcoming formulation, we have paired 1% Pure GHK-Cu with a multi-weight Hyaluronic Acid system

Because of patent economics, BPC-157 will likely never be a formal "FDA-Approved Drug however it will continue to be utilized to try to help heal and recover

up to 20-30% of older adults struggle with it due to lower stomach acid
